High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study.
about
Immune cell-based screening assay for response to anticancer agents: applications in pharmacogenomics.Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective studyHER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support.
P2860
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
High-dose consolidation chemot ...... cancer: a dose finding study.
@en
High-dose consolidation chemot ...... cancer: a dose finding study.
@nl
type
label
High-dose consolidation chemot ...... cancer: a dose finding study.
@en
High-dose consolidation chemot ...... cancer: a dose finding study.
@nl
prefLabel
High-dose consolidation chemot ...... cancer: a dose finding study.
@en
High-dose consolidation chemot ...... cancer: a dose finding study.
@nl
P2093
P2860
P356
P1476
High-dose consolidation chemot ...... cancer: a dose finding study.
@en
P2093
Del Tacca M
Guarneri V
Innocenti F
P2860
P2888
P304
P356
10.1038/SJ.BMT.1703827
P407
P577
2003-02-01T00:00:00Z